[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,751,888
  • Shares Outstanding, K 29,688
  • Annual Sales, $ 427,540 K
  • Annual Income, $ -21,020 K
  • EBIT $ -66 M
  • EBITDA $ -41 M
  • 60-Month Beta 1.96
  • Price/Sales 3.92
  • Price/Cash Flow 24.61
  • Price/Book 6.59

Options Overview Details

View History
  • Implied Volatility 75.58% (+2.58%)
  • Historical Volatility 77.34%
  • IV Percentile 49%
  • IV Rank 27.52%
  • IV High 133.95% on 10/23/25
  • IV Low 53.41% on 08/28/25
  • Expected Move (DTE 6) 2.13 (3.60%)
  • Put/Call Vol Ratio 0.23
  • Today's Volume 2,326
  • Volume Avg (30-Day) 1,712
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 23,282
  • Open Int (30-Day) 20,435
  • Expected Range 56.89 to 61.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.19
  • Number of Estimates 1
  • High Estimate $-0.19
  • Low Estimate $-0.19
  • Prior Year $0.50
  • Growth Rate Est. (year over year) -138.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.86 +44.42%
on 05/20/26
63.31 -6.79%
on 06/12/26
+16.32 (+38.23%)
since 05/18/26
3-Month
32.21 +83.20%
on 05/06/26
73.64 -19.87%
on 03/23/26
-11.68 (-16.52%)
since 03/18/26
52-Week
32.21 +83.20%
on 05/06/26
170.87 -65.46%
on 12/02/25
-5.42 (-8.41%)
since 06/18/25

Most Recent Stories

More News
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK CITY and NEW ORLEANS , June 19, 2026 /PRNewswire/ -- Kahn Swick & Foti , LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with...

WGS : 59.01 (+4.59%)
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 19, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

WGS : 59.01 (+4.59%)
GeneDx Holdings Corp. (WGS) Securities Fraud Class Action Lawsuit Filed; August 3, 2026, Lead Plaintiff Deadline

Did you buy WGS securities between April 16, 2025, and May 4, 2026?

WGS : 59.01 (+4.59%)
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition - HBSS

SAN FRANCISCO , June 19, 2026 /PRNewswire/ -- GeneDx Holdings ( NASDAQ: WGS ) faces a securities class action after the price of the company's stock cratered $33.42 (-49%) on May 5, 2026 in...

WGS : 59.01 (+4.59%)
WGS EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their Options

WGS : 59.01 (+4.59%)
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 18, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

WGS : 59.01 (+4.59%)
WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA in the GeneDx Holdings Corp. Securities Class Action Where Investors Lost $33.42 Per Share

WGS : 59.01 (+4.59%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines - WGS

NEW YORK , June 18, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors...

WGS : 59.01 (+4.59%)
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

NEW YORK , June 17, 2026 /PRNewswire/ --

WGS : 59.01 (+4.59%)
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

WGS : 59.01 (+4.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 62.38
2nd Resistance Point 60.90
1st Resistance Point 59.96
Last Price 59.01
1st Support Level 57.53
2nd Support Level 56.05
3rd Support Level 55.11

See More

52-Week High 170.87
Fibonacci 61.8% 117.90
Fibonacci 50% 101.54
Fibonacci 38.2% 85.18
Last Price 59.01
52-Week Low 32.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.